Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms

Background With recurrence rates after primary cytoreductive surgery (CRS) in excess of 50 per cent, repeat CRS is being performed increasingly, but survival outcomes have not been reported widely. This study examined the outcomes following repeat CRS for appendiceal cancer with peritoneal surface m...

Full description

Bibliographic Details
Main Authors: J. B. Karpes, J. D. Lansom, M. Alshahrani, R. Parikh, R. Shamavonian, N. A. Alzahrani, W. Liauw, D. L. Morris
Format: Article
Language:English
Published: Oxford University Press 2020-06-01
Series:BJS Open
Online Access:https://doi.org/10.1002/bjs5.50262